In vitro delivery of antisense oligonucleotides.
Jääskeläinen
Ilpo
I
Department of Pharmaceutics, University of Kuopio, POB 1627, FIN-70211 Kuopio, Finland.
Honkakoski
Paavo
P
Urtti
Arto
A
D000818:Animals; D002784:Cholesterol; D004337:Drug Carriers; D016503:Drug Delivery Systems; D005229:Fatty Acids, Monounsaturated; D018014:Gene Transfer Techniques; D008081:Liposomes; D016376:Oligonucleotides, Antisense / Q000008:administration & dosage*; D010714:Phosphatidylethanolamines; D011094:Polyethyleneimine; D011107:Polylysine; D011108:Polymers; D000644:Quaternary Ammonium Compounds; D013873:Thionucleotides / Q000008:administration & dosage*
C410262:1,2-dioleoyl-glycero-3-phosphatidyl ethanolamine; D004337:Drug Carriers; D005229:Fatty Acids, Monounsaturated; D008081:Liposomes; D016376:Oligonucleotides, Antisense; D010714:Phosphatidylethanolamines; D011108:Polymers; D000644:Quaternary Ammonium Compounds; D013873:Thionucleotides; D011107:Polylysine; D011094:Polyethyleneimine; D002784:Cholesterol; C070046:1,2-dioleoyloxy-3-(trimethylammonium)propane